久久久久女教师免费一区-久久久久女人精品毛片-久久久久女人爽女人爽-久久久久欧美激情-久久久久欧美精品-久久久久琪琪精品色

dynamic
動態(tài)

轉(zhuǎn)自美聯(lián)社:BON Announces Revolutionary Postbiotic Blood Sugar Solution Nears Patent Launch

2025-03-28

Bon Natural Life Limited (Nasdaq: BON) (“BON” or the “Company”), a leading bio-ingredient solution provider in the natural, health and personal care industry, announced on Thursday, March 20 that a game-changing patent for a natural postbiotic ingredient designed to regulate blood sugar was gearing up for release.

Yongwei Hu, CEO & Chairman of BON, said “Backed by a robust IP strategy, BON is aggressively pursuing global patent protection. Over the next two years, we plan to lock down approvals across top markets, safeguarding our innovation while positioning ourselves for long-term dominance in the fast-growing metabolic health space. This strategic move not only shields the technology but also primes the business for scalable revenue growth and investor appeal.”

As China pushes its Healthy China 2030 agenda, the health industry is riding a sustained growth wave. According to iiMedia Data, a local authoritative third-party data monitoring institution, the market size of China’s health food products industry in 2023 exceeded 328 billion RMB ($45.5 billion), and is expected to reach 423.7 billion RMB ($58.8 billion) by 2027. Among them, vitamins and dietary supplements (VDS) account for over half of the total market. While China’s VDS spending per capita remains 22% of the U.S. levels, analysts project accelerated demand driven by aging demographics and preventive healthcare trends.

BON is positioning itself at the forefront of this fastest-growing industry. A strategic partnership built on March 9 with China’s agricultural giant Sanzhuliang Group Co., Ltd. signals BON’s ambition to bridge farming and biotech. The collaboration, facilitated by the Listed Companies Division of Commercial Culture Association of China, will focus on biotech innovation, functional food R&D, smart agriculture, industry standards, and more. An expert workstation under the Division was launched at BON’s headquarters to advance digital transformation and promote traditional Chinese medicine globally.

The Company’s recent stock surge underscores investor confidence in its leadership in China’s trillion-dollar functional food market. On Friday, March 14, BON stock skyrocketed over 300%, triggering multiple trading halts. Days later, BON priced a best efforts offering of $12 million, before deducting placement agent fees and other estimated expenses payable by the Company. BON intends to use the net proceeds from this offering for R&D, product expansion, global marketing and other corporate purposes.

As one of the few suppliers of stachyose, an extract from stachy affinis and also a prebiotic that can promote human intestinal health, BON has built an international footprint with products sold across Asia, the U.S., and the EU. Its portfolio includes stachyose, apple polyphenols, broccoli extracts, and proprietary formulations like probiotic powder drinks and micro-eco repair shampoos.

About Bon Natural Life Limited (“BON”)

BON is a Cayman Islands company engaged in the business of natural, health, and personal care industries. For more information, please visit the Company’s website at http://www.bnlus.com.

文章來源:美聯(lián)社https://www.universalpressrelease.com/?pr=bon-announces-revolutionary-postbiotic-blood-sugar-solution-nears-patent-launch


推薦新聞

主站蜘蛛池模板: 一级a毛片免费 | 久久lu| 亚洲成人免费看 | 在线观看麻豆国产精品 | 国产精品国产高清国产专区 | 91国视频在线 | 爱爱小视频在线观看网站 | 精品久久久久久久久中文字幕 | 免费一级欧美大片在线观看 | 毛片大| 在线欧美v日韩v国产精品v | 欧美一级高清片在线 | 精品久久国产老人久久综合 | 国产精品免费观在线 | 囗交免费毛片 | 亚洲综合网在线观看 | 日韩精品一区二区三区免费观看 | 精品视频久久久久 | 午夜主播国产福利视频在线 | 亚洲区欧美中文字幕久久 | 日本视频中文字幕一区二区 | 亚洲欧美不卡中文字幕 | 亚洲视频区 | 成人午夜大片免费视频77777 | 免费视频性| 一级片免费网址 | 亚洲一级毛片免观看 | 久久免费视频6 | 国产不卡视频在线播放 | 国产精品福利在线观看入口 | 精品美女 | 中文字幕一区2区 | 香蕉免费一区二区三区在线观看 | 性生活视频网 | 亚洲综合首页 | 国产男女爱视频在线观看 | 成人激情视频在线 | 99国产精品视频免费观看 | 1000部羞羞禁止免费观看视频 | 中文字幕日韩国产 | 99久热成人精品视频 |